Petros Christopoulos wrote: >I would like to ask if anybody knows about the relationship of >expression of classical >proliferation markers (like Ki-67 or the transferrin receptor) and >CD25 (which is also an activation marker) in peripheral blood lymphocytes. >Do they give similar results, do they correlate or are they totally >independent of each >other ? Time to start another winning streak for Mailing List submissions... See Figure 10-7, p.460, in the 4th Edition of Practical Flow Cytometry (available without charge on the Invitrogen/Molecular Probes web site, http://probes.invitrogen.com/) for plots relating transferrin receptor (CD71) expression and RNA content to DNA content. I have speculated in the book and on this Mailing List that Ki-67 and CD71 should correlate almost absolutely in proliferating lymphocytes and probably in most or all other cell types, but, when I just looked on PubMed, I could not find any publication suggesting that both had been measured simultaneously in the same cells at the same time. This really needs to be done; there have been over 100 papers published referring to Ki-67 in the past year, representing a lot of work by many people. Detecting Ki-67 requires permeabilization and is only possible in fixed cells, whereas detecting CD71 requires only surface staining, meaning that live cells can easily be analyzed and sorted based on CD71 status, but not based on Ki-67 status. If the two markers are as well correlated as I suspect, a switch from Ki-67 to CD71 staining will save both time and money, and, more importantly, allow researchers to do further functional studies on live cells precisely characterized as to cell cycle position. Such studies can, in at least some cases (see the work of Edward Srour et al), be done using Hoechst 33342/Pyronin Y staining for DNA and RNA, but pyronin Y can be toxic. [] The above, unpublished data from experiments done eight or nine years ago, shows that in CD4+ lymphocytes gated from cells in a mixed lymphocyte reaction, CD25 expression apparently occurs all cells in G1, S, G2, and M phases of the cell cycle (the quadrant lines are not set well; the horizontal line should be lower, and the vertical line closer to the vertical axis). We only did simultaneous staining of CD25 and CD71 on a couple of occasions, since we were typically staining for DNA (Hoechst 33342), RNA (pyronin Y), and CD4 or CD8 (PE-Cy5) as well as for the activation antigen (fluorescein). I could not find a plot of CD25 vs. CD71, but my recollection is that they were close to absolutely correlated, as the plot above and the figure in the book would suggest. >If they do correlate, how would an increased activation status of >the immune system >(increased percentage or number of HLA-DR+ cells) be expected to >influence that >relationship ? Again, based on work done many years ago, we found that HLA-DR expression was a rather poor indicator of lymphocyte activation; HLA-DR did not come up until about 72 hr after cells were stimulated by lectin or alloantigen, and HLA-DR was not expressed on many cells that could be shown to be in proliferative (G1,S, G2, M) phases of the cycle. In the era of 18-color flow cytometric analysis, it should not be that difficult to answer your question definitively by simultaneously measuring and subsequently correlating correlating expression of multiple activation antigens with DNA and RNA content (cell cycle phase) and with both T-cell phenotype (CD4+, CD8+, etc.) and memory class. That's more Mario Roederer's line of work than mine these days. Holiday Greetings to all, -Howard This attachment - '2d861eb6.jpg' - 31.48 KBytes - can be viewed at http://www.cyto.purdue.edu/MD-parts/33fde94f112fa3896689b31dcd69ee274064aaff.jpgReceived on Fri Dec 23 20:18:00 2005
This archive was generated by hypermail 2.1.8 : Sat Jan 14 2006 - 22:04:01 EST